“Patient Centricity” is finally paying off for drug companies in a BIG way, but it has nothing to do with designing more effective clinical trials or better marketing. It has everything to do with influencing lawmakers and especially the FDA.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
